Hunan Historical Balance Sheet
603998 Stock | 11.49 0.21 1.86% |
Trend analysis of Hunan Fangsheng Pharm balance sheet accounts such as Other Current Liab of 6.7 M, Total Current Liabilities of 1.3 B or Total Stockholder Equity of 1 B provides information on Hunan Fangsheng's total assets, liabilities, and equity, which is the actual value of Hunan Fangsheng Pharm to its prevalent stockholders. By breaking down trends over time using Hunan Fangsheng balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Hunan Fangsheng Pharm latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hunan Fangsheng Pharm is a good buy for the upcoming year.
Hunan Fangsheng Inventory |
|
Hunan |
About Hunan Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Hunan Fangsheng Pharm at a specified time, usually calculated after every quarter, six months, or one year. Hunan Fangsheng Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Hunan Fangsheng and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Hunan currently owns. An asset can also be divided into two categories, current and non-current.
Hunan Fangsheng Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Hunan Fangsheng assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Hunan Fangsheng Pharm books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Hunan Fangsheng balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Hunan Fangsheng Pharm are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Most accounts from Hunan Fangsheng's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Hunan Fangsheng Pharm current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Hunan Fangsheng Pharm. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Hunan Fangsheng's Total Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Accounts Payable is expected to grow to about 258.1 M, whereas Total Assets are forecasted to decline to about 1.7 B.
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 626.4M | 271.5M | 7.1M | 6.7M | Total Assets | 2.7B | 2.9B | 3.1B | 1.7B |
Hunan Fangsheng balance sheet Correlations
Click cells to compare fundamentals
Hunan Fangsheng Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hunan Fangsheng balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 2.0B | 2.2B | 2.7B | 2.9B | 3.1B | 1.7B | |
Other Current Liab | 126.2M | 137.0M | 626.4M | 271.5M | 7.1M | 6.7M | |
Total Current Liabilities | 689.1M | 876.5M | 1.3B | 999.6M | 1.2B | 1.3B | |
Total Stockholder Equity | 1.1B | 1.2B | 1.2B | 1.4B | 1.5B | 1.0B | |
Other Liab | 73.1M | 75.2M | 80.6M | 70.9M | 81.5M | 55.0M | |
Retained Earnings | 578.1M | 590.5M | 634.8M | 816.7M | 715.9M | 486.4M | |
Accounts Payable | 94.9M | 103.5M | 117.2M | 165.6M | 245.8M | 258.1M | |
Cash | 156.1M | 318.8M | 258.9M | 399.7M | 209.0M | 292.0M | |
Other Assets | 133.0M | 172.3M | 192.2M | 116.7M | 134.2M | 75.9M | |
Net Receivables | 203.2M | 182.9M | 243.3M | 177.5M | 209.6M | 131.4M | |
Inventory | 206.5M | 209.8M | 256.7M | 303.4M | 328.3M | 180.9M | |
Other Current Assets | 45.8M | 41.8M | 50.7M | 90.8M | 13.7M | 13.0M | |
Total Liab | 792.5M | 977.0M | 1.4B | 1.4B | 1.5B | 1.6B | |
Intangible Assets | 242.5M | 227.0M | 250.0M | 273.7M | 267.7M | 178.7M | |
Common Stock | 428.6M | 434.5M | 429.4M | 439.3M | 505.2M | 322.8M | |
Property Plant Equipment | 601.4M | 657.1M | 823.0M | 841.3M | 967.4M | 1.0B | |
Net Tangible Assets | 632.2M | 673.8M | 567.4M | 870.0M | 783.0M | 573.6M | |
Deferred Long Term Liab | 36.3M | 43.0M | 41.1M | 8.1M | 9.3M | 8.8M | |
Total Current Assets | 644.9M | 795.7M | 866.6M | 1.2B | 920.7M | 841.1M | |
Non Current Assets Total | 1.3B | 1.4B | 1.8B | 1.7B | 2.2B | 1.5B | |
Non Currrent Assets Other | 45.6M | 78.2M | 103.7M | 75.2M | 116.0M | 63.2M | |
Good Will | 252.1M | 250.9M | 378.7M | 246.4M | 274.4M | 234.5M | |
Non Current Liabilities Total | 103.4M | 100.5M | 145.4M | 414.6M | 244.2M | 161.8M | |
Short Long Term Debt | 275.7M | 408.5M | 443.5M | 210.2M | 309.2M | 269.3M | |
Common Stock Shares Outstanding | 428.6M | 434.5M | 429.4M | 439.6M | 439.7M | 476.5M | |
Net Invested Capital | 1.4B | 1.6B | 1.7B | 1.9B | 1.9B | 1.7B | |
Net Working Capital | (44.2M) | (80.8M) | (388.8M) | 191.5M | (327.4M) | (311.0M) |
Currently Active Assets on Macroaxis
Other Information on Investing in Hunan Stock
Balance Sheet is a snapshot of the financial position of Hunan Fangsheng Pharm at a specified time, usually calculated after every quarter, six months, or one year. Hunan Fangsheng Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Hunan Fangsheng and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Hunan currently owns. An asset can also be divided into two categories, current and non-current.